These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 29347935

  • 1. Real-world experience of women using extended-cycle vs monthly-cycle combined oral contraception in the United States: the National Health and Wellness Survey.
    Nappi RE, Lete I, Lee LK, Flores NM, Micheletti MC, Tang B.
    BMC Womens Health; 2018 Jan 18; 18(1):22. PubMed ID: 29347935
    [Abstract] [Full Text] [Related]

  • 2. Randomized trial of the effect of tailored versus standard use of the combined oral contraceptive pill on continuation rates at 1 year.
    Stephenson J, Shawe J, Panicker S, Brima N, Copas A, Sauer U, Wilkinson C, Akintomide H, O'Brien P.
    Contraception; 2013 Oct 18; 88(4):523-31. PubMed ID: 23663917
    [Abstract] [Full Text] [Related]

  • 3. Treatment continuation and satisfaction in women using combined oral contraception with nomegestrol acetate and oestradiol: a multicentre, prospective cohort study (BOLERO).
    Cagnacci A, Bastianelli C, Neri M, Cianci A, Benedetto C, Calanni L, Vignali M, De Leo V, Cicinelli E, Borrelli G, Volpe A, ; The BOLERO Study Writing Group.
    Eur J Contracept Reprod Health Care; 2018 Dec 18; 23(6):393-399. PubMed ID: 30465698
    [Abstract] [Full Text] [Related]

  • 4. Continuous or extended cycle vs. cyclic use of combined oral contraceptives for contraception.
    Edelman AB, Gallo MF, Jensen JT, Nichols MD, Schulz KF, Grimes DA.
    Cochrane Database Syst Rev; 2005 Jul 20; (3):CD004695. PubMed ID: 16034942
    [Abstract] [Full Text] [Related]

  • 5. Extended regimen combined oral contraception: A review of evolving concepts and acceptance by women and clinicians.
    Nappi RE, Kaunitz AM, Bitzer J.
    Eur J Contracept Reprod Health Care; 2016 Jul 20; 21(2):106-15. PubMed ID: 26572318
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Women's preferences for menstrual bleeding frequency: results of the Inconvenience Due to Women's Monthly Bleeding (ISY) survey.
    Nappi RE, Fiala C, Chabbert-Buffet N, Häusler G, Jamin C, Lete I, Lukasiewic M, Pintiaux A, Lobo P.
    Eur J Contracept Reprod Health Care; 2016 Jun 20; 21(3):242-50. PubMed ID: 27010535
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Oral Tranexamic Acid versus Combined Oral Contraceptives for Adolescent Heavy Menstrual Bleeding: A Pilot Study.
    Srivaths LV, Dietrich JE, Yee DL, Sangi-Haghpeykar H, Mahoney D.
    J Pediatr Adolesc Gynecol; 2015 Aug 20; 28(4):254-7. PubMed ID: 26024940
    [Abstract] [Full Text] [Related]

  • 10. Women's preferences for menstrual bleeding frequency in 12 European countries: the Inconvenience Due to Women's Monthly Bleeding (ISY) survey.
    Fiala C, Chabbert-Buffet N, Häusler G, Jamin C, Lete I, Lobo P, Nappi RE, Pintiaux A.
    Eur J Contracept Reprod Health Care; 2017 Aug 20; 22(4):268-273. PubMed ID: 28650776
    [Abstract] [Full Text] [Related]

  • 11. Mental Health Symptoms in Oral Contraceptive Users During Short-Term Hormone Withdrawal.
    Noachtar IA, Frokjaer VG, Pletzer B.
    JAMA Netw Open; 2023 Sep 05; 6(9):e2335957. PubMed ID: 37755829
    [Abstract] [Full Text] [Related]

  • 12. Effect on quality of life of switching to combined oral contraception based on natural estrogen: an observational, multicentre, prospective phase IV study (ZOCAL Study).
    Lete I, de la Viuda E, Pérez-Campos E, Martínez MÁ, Sanchez-de la Rosa R, Novalbos J, Sánchez-Borrego R.
    Eur J Contracept Reprod Health Care; 2016 Aug 05; 21(4):276-84. PubMed ID: 27220697
    [Abstract] [Full Text] [Related]

  • 13. Combined oral contraceptive use is associated with both improvement and worsening of mood in the different phases of the treatment cycle-A double-blind, placebo-controlled randomized trial.
    Lundin C, Danielsson KG, Bixo M, Moby L, Bengtsdotter H, Jawad I, Marions L, Brynhildsen J, Malmborg A, Lindh I, Sundström Poromaa I.
    Psychoneuroendocrinology; 2017 Feb 05; 76():135-143. PubMed ID: 27923181
    [Abstract] [Full Text] [Related]

  • 14. Femiject, a once-a-month combined injectable contraceptive: experience from Pakistan.
    Izhar R, Husain S, Tahir MA, Husain S.
    Eur J Contracept Reprod Health Care; 2020 Oct 05; 25(5):359-364. PubMed ID: 32757796
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A prospective follow-up of two 21/7 cycles followed by two extended regimen 84/7 cycles with contraceptive pills containing ethinyl estradiol and drospirenone.
    Seidman DS, Yeshaya A, Ber A, Amodai I, Feinstein I, Finkel I, Gordon N, Porat N, Samuel D, Shiran-Makler E, Wolman I.
    Isr Med Assoc J; 2010 Jul 05; 12(7):400-5. PubMed ID: 20862819
    [Abstract] [Full Text] [Related]

  • 17. Attitudes, knowledge and prescribing habits of Brazilian gynecologists regarding extended-cycle oral contraceptives.
    Pompei LM, Fernandes CE, Steiner ML, Strufaldi R, Melo NR.
    Gynecol Endocrinol; 2013 Dec 05; 29(12):1071-4. PubMed ID: 24000934
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Contraception containing estradiol valerate and dienogest--advantages, adherence and user satisfaction.
    Graziottin A.
    Minerva Ginecol; 2014 Oct 05; 66(5):479-95. PubMed ID: 25245997
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.